Detalhe da pesquisa
1.
Cl-NQTrp Alleviates Tauopathy Symptoms in a Model Organism through the Inhibition of Tau Aggregation-Engendered Toxicity.
Neurodegener Dis
; 17(2-3): 73-82, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27760426
2.
Monitoring and targeting the initial dimerization stage of amyloid self-assembly.
Angew Chem Int Ed Engl
; 54(7): 2062-7, 2015 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25533189
3.
Generic inhibition of amyloidogenic proteins by two naphthoquinone-tryptophan hybrid molecules.
Proteins
; 80(8): 1962-73, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22488522
4.
Quantitative structure-activity relationship analysis of ß-amyloid aggregation inhibitors.
J Comput Aided Mol Des
; 25(2): 135-44, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21165759
5.
Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity.
J Alzheimers Dis
; 51(1): 165-78, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26836184
6.
Methylations of tryptophan-modified naphthoquinone affect its inhibitory potential toward Aß aggregation.
J Phys Chem B
; 117(6): 1780-9, 2013 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23259849
7.
Orally administrated cinnamon extract reduces ß-amyloid oligomerization and corrects cognitive impairment in Alzheimer's disease animal models.
PLoS One
; 6(1): e16564, 2011 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21305046
8.
Complete phenotypic recovery of an Alzheimer's disease model by a quinone-tryptophan hybrid aggregation inhibitor.
PLoS One
; 5(6): e11101, 2010 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-20559435